The preliminary results for Johnson & Johnson’s (J&J) late-stage Covid-19 vaccine trial should be available by January 21 and will then be submitted to the US Food and Drug Administration, according to the protocol chair for the local arm of the trial, Medical Research Council president Glenda Gray.
Trending:
J&J vaccine results expected by January 21